Tantum rose, vaginal 500 mg 10 pcs

• In the postpartum period as a therapeutic and prophylactic agent for the prevention of postpartum infectious complications.
• specific vulvovaginitis (in combination therapy);
• unspecific vulvovaginitis and cervicovaginitis of any etiology, including those secondary to chemotherapy and radiotherapy;
• bacterial vaginosis;
• prevention of post-operative infectious complications in operative gynecology.

.

Indications

In the postpartum period as a therapeutic and prophylactic agent for the prevention of postpartum infectious complications.
specific vulvovaginitis (in complex therapy);
nonspecific vulvovaginitis and cervicovaginitis of any etiology, including those secondary to chemotherapy and radiotherapy;
bacterial vaginosis;
prevention of postoperative infectious complications in surgical gynecology.

Pharmacological effect

Pharmacotherapeutic group:

Special instructions

Long-term use of the drug may lead to hypersensitivity. When using the drug for long periods, consult a doctor.

Impact on the ability to drive vehicles and operate machinery:

Active ingredient

Benzydamine

Composition

For one sachet of powder for the preparation of vaginal solution 500 mg:

Active component – benzydamine hydrochloride – 0.500 g;.

Auxiliary components:

trimethylacetylammonium-p-toluenesulfonate,
povidone,
sodium chloride.

Contraindications

Hypersensitivity to any of the components of the drug.

Side Effects

In rare cases, allergic reactions and dryness of the oral mucosa are possible.

Interaction

No clinically significant interaction of the drug Tantum® Rose with other drugs has been established.

Overdose

Currently, no cases of overdose of Tantum® Rose have been reported.

Storage conditions

In a place protected from light, at a temperature not exceeding 25 °C.

Shelf life

5 years.

Manufacturer

Aziende Chimique Riunite Angelini Francesco A.C.R.A., Italy